Description

Dinastat (parecoxib) powder for infusions 40 mg. vial №5

Ingredients:

Each vial contains 40 mg of parecoxib.

Dosage:

The usual dose is 40 mg administered by intravenous infusion over 15 minutes every 12 hours.

Indications:

Dinastat is indicated for the relief of acute postoperative pain.

Contraindications:

Do not use Dinastat in patients with known hypersensitivity to parecoxib or other NSAIDs.

Directions:

Administer Dinastat as directed by a healthcare provider. It should only be used for the shortest duration consistent with individual patient treatment goals.

Scientific Evidence:

Parecoxib, the active ingredient in Dinastat, is a prodrug of valdecoxib, a COX-2 inhibitor. Studies have shown that parecoxib effectively reduces postoperative pain and opioid consumption, making it a valuable option in the management of acute pain following surgery.

Additional Information:

Dinastat has been extensively studied in various clinical trials, demonstrating its efficacy and safety profile. It offers a convenient dosing regimen and can be a beneficial addition to multimodal analgesic strategies in postoperative care.

Compared to traditional NSAIDs, Dinastat has a lower risk of gastrointestinal adverse effects due to its selective inhibition of COX-2. This makes it a preferred choice in patients where such risks need to be minimized.